Chronic kidney disease (CKD) requires collaborative and comprehensive management. CKD progresses through stages and can lead to end-stage kidney disease (ESKD) if untreated. Interprofessional collaboration and patient education are crucial, enabling patients to manage their health and improve their quality of life.
The diagnosis of CKD primarily focuses on the glomerular filtration rate (GFR), which assesses kidney function by measuring how well kidneys filter blood. Additionally, serum creatinine and blood urea nitrogen (BUN) levels are monitored to evaluate kidney health. Early signs of CKD often include proteinuria, an indicator of kidney damage that requires timely intervention to slow disease progression. Imaging studies provide insights into underlying conditions; for instance, renal ultrasounds measure kidney size and detect obstructions, while CT scans identify kidney stones and tumors. A kidney biopsy can confirm diagnoses such as glomerulonephritis in specific cases, facilitating precise treatment planning.
Medical management centers on controlling hypertension, a major contributor to CKD progression. Blood pressure control, typically below 125–130/80 mm Hg, is achieved through ACE inhibitors or angiotensin II receptor blockers, reducing proteinuria and protecting kidney function. Additional risk factors like hyperglycemia, smoking, and obesity are addressed through lifestyle interventions and medications. Hyperkalemia, a common complication, is managed by limiting dietary potassium, using potassium-binding agents like patiromer, and stabilizing cardiac membranes with calcium gluconate in acute cases. Insulin administration is also effective as it shifts potassium back into cells.
Dialysis becomes essential for patients with ESKD or severe complications, such as fluid overload, hyperkalemia, or metabolic acidosis. Depending on the patient's clinical status and preferences, treatment options include hemodialysis, peritoneal dialysis, and continuous renal replacement therapy. Dialysis filters toxins and excess fluids from the blood, compensating for lost kidney function and stabilizing electrolyte levels.
Nutritional therapy plays a vital role in managing CKD. For patients not on dialysis, protein intake is generally limited to 0.6–1.0 grams per kilogram of body weight per day to reduce metabolic waste and kidney workload. Dialysis patients, however, require more protein due to protein loss during treatment, with a recommended intake of 1.2–1.3 grams per kilogram per day. Sodium, potassium, and phosphorus are also carefully regulated to maintain electrolyte balance and prevent complications like hyperkalemia and mineral bone disorders. A renal dietitian’s guidance is invaluable for individualized nutrition management and ensuring adequate caloric and nutrient intake.
Chronic Kidney Disease requires collaborative management.
Diagnosis involves measuring the glomerular filtration rate and serum creatinine, with early signs like proteinuria.
Imaging studies such as renal ultrasound assess kidney size and obstruction, CT scans detect stones and tumors, and kidney biopsy helps diagnose diseases like glomerulonephritis.
Medical management involves controlling hypertension with ACE inhibitors or angiotensin II receptor blockers to protect kidney function.
Hyperkalemia management involves dietary potassium restrictions and medications like patiromer; in emergencies, calcium gluconate stabilizes cardiac membranes, while insulin promotes cellular potassium uptake.
Dialysis is indicated for patients with end-stage kidney disease or severe complications, like fluid overload, hyperkalemia, or metabolic acidosis.
Options include hemodialysis, peritoneal dialysis, and continuous renal replacement therapy.
Nutrition therapy limits protein intake to 0.6–1.0 g/kg/day for non-dialysis patients and 1.2–1.3 g/kg/day for dialysis patients.
繁體中文
